Track the 바이오다인 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오다인 has published 28 public disclosures. Market capitalisation: €252.9bn. The latest transaction was filed on 13 July 2026 (Other). Among the most active insiders: 임욱빈. All data is openly available.
28
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
9 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,787 of 26,270 companies
52.6
score / 100
Value
32
Quality
73
FCF yld-1.9%
Earn yld0.3%
EV/EBITDA·
ROE3.3%
Gross mgn64%
Net mgn12%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
BioDine is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the medical sector.